1. Home
  2. SLND vs LITS Comparison

SLND vs LITS Comparison

Compare SLND & LITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southland Holdings Inc.

SLND

Southland Holdings Inc.

HOLD

Current Price

$0.67

Market Cap

31.4M

Sector

Industrials

ML Signal

HOLD

LITS

Lite Strategy Inc.

HOLD

Current Price

$0.94

Market Cap

25.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLND
LITS
Founded
1900
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.4M
25.7M
IPO Year
2021
2003

Fundamental Metrics

Financial Performance
Metric
SLND
LITS
Price
$0.67
$0.94
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
574.3K
113.6K
Earning Date
05-11-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$772,168,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.51
$0.69
52 Week High
$5.34
$3.03

Technical Indicators

Market Signals
Indicator
SLND
LITS
Relative Strength Index (RSI) 49.82 50.86
Support Level $0.64 $0.89
Resistance Level $0.75 $0.99
Average True Range (ATR) 0.08 0.05
MACD 0.01 -0.00
Stochastic Oscillator 63.84 59.14

Price Performance

Historical Comparison
SLND
LITS

About SLND Southland Holdings Inc.

Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures. The company operates in two distinct segments: Civil and Transportation. The civil segment operates throughout North America and specializes in services that include the design and construction of water pipelines, pump stations, lift stations, water and wastewater treatment plants, concrete and structural steel, outfall, and tunneling. The transportation segment operates throughout North America and specializes in services that include the design and construction of bridges, roadways, marine, dredging, ship terminals and piers, and specialty structures and facilities.

About LITS Lite Strategy Inc.

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.

Share on Social Networks: